MetLife Investment Management’s Acadia Healthcare ACHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $34.9K | Buy |
1,491
+2
| +0.1% | +$36 | ﹤0.01% | 2707 |
|
|
2025
Q4 | $21.1K | Sell |
1,489
-28
| -2% | -$530 | ﹤0.01% | 2780 |
|
|
2025
Q3 | $37.6K | Sell |
1,517
-48,069
| -97% | -$1.07M | ﹤0.01% | 2810 |
|
|
2025
Q2 | $1.13M | Sell |
49,586
-1,959
| -4% | -$46.4K | 0.01% | 1246 |
|
|
2025
Q1 | $1.56M | Sell |
51,545
-781
| -1% | -$29.8K | 0.01% | 1152 |
|
|
2024
Q4 | $2.07M | Buy |
52,326
+4,362
| +9% | +$197K | 0.01% | 1014 |
|
|
2024
Q3 | $3.04M | Sell |
47,964
-857
| -2% | -$61.9K | 0.02% | 802 |
|
|
2024
Q2 | $3.3M | Sell |
48,821
-1,791
| -4% | -$125K | 0.02% | 729 |
|
|
2024
Q1 | $4.01M | Sell |
50,612
-1,336
| -3% | -$109K | 0.03% | 617 |
|
|
2023
Q4 | $4.04M | Sell |
51,948
-824
| -2% | -$61K | 0.03% | 601 |
|
|
2023
Q3 | $3.71M | Sell |
52,772
-2,337
| -4% | -$175K | 0.03% | 602 |
|
|
2023
Q2 | $4.39M | Sell |
55,109
-638
| -1% | -$46.1K | 0.03% | 528 |
|
|
2023
Q1 | $4.03M | Sell |
55,747
-1,493
| -3% | -$116K | 0.03% | 591 |
|
|
2022
Q4 | $4.71M | Sell |
57,240
-1,063
| -2% | -$87.6K | 0.04% | 470 |
|
|
2022
Q3 | $4.56M | Sell |
58,303
-536
| -0.9% | -$42.8K | 0.04% | 455 |
|
|
2022
Q2 | $3.98M | Buy |
58,839
+706
| +1% | +$49.3K | 0.03% | 560 |
|
|
2022
Q1 | $3.81M | Buy |
58,133
+14,549
| +33% | +$845K | 0.02% | 692 |
|
|
2021
Q4 | $2.65M | Buy |
43,584
+413
| +1% | +$24.6K | 0.02% | 741 |
|
|
2021
Q3 | $2.75M | Sell |
43,171
-1,669
| -4% | -$105K | 0.02% | 690 |
|
|
2021
Q2 | $2.81M | Sell |
44,840
-1,152
| -3% | -$72.2K | 0.02% | 713 |
|
|
2021
Q1 | $2.63M | Sell |
45,992
-2,705
| -6% | -$146K | 0.02% | 742 |
|
|
2020
Q4 | $2.45M | Sell |
48,697
-2,237
| -4% | -$89.2K | 0.02% | 725 |
|
|
2020
Q3 | $1.5M | Sell |
50,934
-1,885
| -4% | -$54.7K | 0.02% | 846 |
|
|
2020
Q2 | $1.33M | Buy |
52,819
+1,979
| +4% | +$49.4K | 0.02% | 910 |
|
|
2020
Q1 | $933K | Hold |
50,840
| – | – | 0.01% | 932 |
|
|
2019
Q4 | $1.69M | Sell |
50,840
-648
| -1% | -$20.3K | 0.02% | 871 |
|
|
2019
Q3 | $1.6M | Sell |
51,488
-1,064
| -2% | -$32.4K | 0.02% | 867 |
|
|
2019
Q2 | $1.84M | Sell |
52,552
-1,365
| -3% | -$44.1K | 0.02% | 853 |
|
|
2019
Q1 | $1.58M | Buy |
53,917
+104
| +0.2% | +$2.95K | 0.02% | 905 |
|
|
2018
Q4 | $1.38M | Sell |
53,813
-228
| -0.4% | -$7.89K | 0.02% | 909 |
|
|
2018
Q3 | $1.9M | Buy |
54,041
+2,468
| +5% | +$98.3K | 0.02% | 880 |
|
|
2018
Q2 | $2.11M | Buy |
51,573
+529
| +1% | +$21.3K | 0.02% | 775 |
|
|
2018
Q1 | $2M | Sell |
51,044
-636
| -1% | -$23.3K | 0.02% | 778 |
|
|
2017
Q4 | $1.69M | Buy |
+51,680
| New | +$1.79M | 0.02% | 844 |
|
Other funds holding ACHC
KCM
VPM
DM
DCM
ABI
VCM
MetLife Investment Management's ACHC Position: Q1 2026 in Review
MetLife Investment Management increased its Acadia Healthcare (ACHC) stake by 0.13% in Q1 2026, buying an estimated $36 and bringing the position to 1,491 shares worth $34.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2707.
MetLife Investment Management first reported a position in ACHC in Q4 2017 and has held it in 34 quarters since. The position peaked at $4.71M in Q4 2022. 295 funds tracked by Wall St. Rank hold ACHC as of Q1 2026.
- MetLife Investment Management held 1,491 shares of Acadia Healthcare worth $34.9K as of Q1 2026.
- MetLife Investment Management bought 2 Acadia Healthcare shares in Q1 2026, an estimated $36.
- Acadia Healthcare made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #2707 holding.
- MetLife Investment Management first reported a position in Acadia Healthcare in Q4 2017 and has held it in 34 quarters since.
- MetLife Investment Management's Acadia Healthcare position peaked at $4.71M in Q4 2022.
- 295 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2026.
Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.